Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Diabetes

Towards a coxsackievirus B-based vaccine to combat T1DM

The role of group B coxsackieviruses (CVB) in the pathogenesis of type 1 diabetes mellitus (T1DM) remains controversial. A recent report by Stone et al. showed that a CVB1-based vaccine can protect against both CVB1 infection and CVB1-induced T1DM in mouse models. This tool could help to elucidate the relationship between CVB and T1DM.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hober, D. & Sauter, P. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat. Rev. Endocrinol. 6, 279–289 (2010).

    Article  Google Scholar 

  2. Hober, D. & Alidjinou, E. K. Enteroviral pathogenesis of type 1 diabetes: queries and answers. Curr. Opin. Infect. Dis. 26, 263–269 (2013).

    Article  CAS  Google Scholar 

  3. Stone, V. M. et al. A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes. Diabetologia 61, 476–481 (2018).

    Article  CAS  Google Scholar 

  4. Drescher, K. M., von Herrath, M. & Tracy, S. Enteroviruses, hygiene and type 1 diabetes: toward a preventive vaccine. Rev. Med. Virol. 25, 19–32 (2015).

    Article  CAS  Google Scholar 

  5. Krogvold, L. et al. Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes 64, 1682–1687 (2015).

    Article  CAS  Google Scholar 

  6. Yeung, W.-C. G., Rawlinson, W. D. & Craig, M. E. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 342, d35 (2011).

    Article  Google Scholar 

  7. Op de Beeck, A. & Eizirik, D. L. Viral infections in type 1 diabetes mellitus — why the β cells? Nat. Rev. Endocrinol. 12, 263–273 (2016).

    Article  CAS  Google Scholar 

  8. Morgan, N. G. & Richardson, S. J. Enteroviruses as causative agents in type 1 diabetes: loose ends or lost cause? Trends Endocrinol. Metab. 25, 611–619 (2014).

    Article  CAS  Google Scholar 

  9. Flodström, M. et al. Target cell defense prevents the development of diabetes after viral infection. Nat. Immunol. 3, 373–382 (2002).

    Article  Google Scholar 

  10. Hyöty, H. & Knip, M. Developing a vaccine for type 1 diabetes through targeting enteroviral infections. Expert Rev. Vaccines 13, 989–999 (2014).

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank their team and all their collaborators.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Didier Hober.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Related links

Related links

FURTHER INFORMATION

nPOD website

PEVNET website

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hober, D., Alidjinou, E. Towards a coxsackievirus B-based vaccine to combat T1DM. Nat Rev Endocrinol 14, 131–132 (2018). https://doi.org/10.1038/nrendo.2017.184

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2017.184

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing